IFNA1 and COVID-19: Deficiencies in the first line IFN defense system may result in impaired type I IFN responses resulting in high blood viral load that are often associated with severe and critical COVID-19 patients [116], while the JAK-STAT signaling pathway may also be suppressed during post-infection by persistent viral reservoirs.